Clinical Trial Update: Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) [Phase 2]

View source ↗

Summary

Phase 2 study assessing vadadustat for prevention and treatment of acute respiratory distress syndrome in hospitalized COVID-19 patients has completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Acute Respiratory Distress Syndrome, Coronavirus Infection | Phase 2 | Status: COMPLETED | Results posted: 2025-03-26